{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:26:37Z","timestamp":1785223597483,"version":"3.55.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Black individuals have a twofold higher rate of prostate cancer death in the US compared with the average population with prostate cancer. Few guidelines support race-conscious screening practices among at-risk Black individuals.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine structural factors that facilitate or impede access to prostate cancer screening among Black individuals in the US.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This qualitative, mixed-methods study was conducted between September 1, 2021, and December 31, 2023, in clinical and community settings across Washington, Wyoming, Alaska, Montana, Idaho, and Oregon. It included semistructured interviews with Black adults (aged \u226518 years) at risk for prostate cancer with or without a history of prostate-specific antigen (PSA) testing and a survey of primary care practitioners (PCPs) and urologists.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Patient and physician experiences, knowledge, attitudes, and practices of PSA testing and prostate cancer screening were evaluated. Consensus coding and thematic analysis were used to analyze interviews; surveys were analyzed using descriptive statistics.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 29 Black men (median [range] age, 59 [32-72] years) participated in the interviews, and 31 PCPs (including 30 phyicians and 1 physician assistant) and 32 urologists (45 of 63 aged 30-59 years [71.4%]; 40 male [63.5%]) participated in the survey. Interview participants perceived that PCPs function as gatekeepers in accessing PSA testing but may lack knowledge specific to Black men\u2019s risk for prostate cancer and hold attitudes about PSA testing that do not support its use. Interview participants also reported a lack of trusted relationships with PCPs to support shared decision-making. While both urologists and PCPs were highly aware of US Preventive Services Task Force guidelines, PCPs were much less likely than urologists to believe in the value of PSA testing or the role of early detection to prevent prostate cancer\u2013related mortality (2 [6.5%] vs 24 [75.0%], respectively).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this qualitative study examining structural factors associated with access to prostate cancer screening among Black individuals, findings from the survey supported participants\u2019 perceptions that PCPs do not value PSA testing for prostate cancer early detection or appreciate its role in reducing the risk of prostate cancer\u2013related mortality. Primary care practitioner reliance on USPSTF guidelines, which currently do not provide guideline recommendations for screening high-risk groups, including Black individuals, suggests that incorporating evidence-driven guidance for PSA screening among Black individuals into these guidelines may substantially improve prostate cancer early detection among this high-risk population.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.30946","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:00:43Z","timestamp":1757343643000},"page":"e2530946","source":"Crossref","is-referenced-by-count":3,"title":["Patient and Physician Perceptions of Prostate-Specific Antigen Testing Among Black Individuals"],"prefix":"10.1001","volume":"8","author":[{"given":"Jenney R.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Urology, Center for Health Outcomes Research and Dissemination, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante\u2019","family":"Morehead","sequence":"additional","affiliation":[{"name":"Department of Urology, Center for Health Outcomes Research and Dissemination, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Young","sequence":"additional","affiliation":[{"name":"Black and African-Descent Collaborative for Prostate Cancer Action, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Tolbert","sequence":"additional","affiliation":[{"name":"Black and African-Descent Collaborative for Prostate Cancer Action, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Masembe","sequence":"additional","affiliation":[{"name":"Black and African-Descent Collaborative for Prostate Cancer Action, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Britt","sequence":"additional","affiliation":[{"name":"Washington State University, Spokane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Neuenschwander","sequence":"additional","affiliation":[{"name":"Washington State University, Spokane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Schuppe","sequence":"additional","affiliation":[{"name":"Washington State University, Spokane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pelman","sequence":"additional","affiliation":[{"name":"Washington State Urology Society, Mill Creek"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debi","family":"Johnson","sequence":"additional","affiliation":[{"name":"Washington State Urology Society, Mill Creek"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vida","family":"Henderson","sequence":"additional","affiliation":[{"name":"Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu F.","family":"Darst","sequence":"additional","affiliation":[{"name":"Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Egwuatu","sequence":"additional","affiliation":[{"name":"Kaiser Permanente, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Min","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Urology, Center for Health Outcomes Research and Dissemination, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika M.","family":"Wolff","sequence":"additional","affiliation":[{"name":"Department of Urology, Center for Health Outcomes Research and Dissemination, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Gore","sequence":"additional","affiliation":[{"name":"Department of Urology, Center for Health Outcomes Research and Dissemination, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaw A.","family":"Nyame","sequence":"additional","affiliation":[{"name":"Department of Urology, Center for Health Outcomes Research and Dissemination, University of Washington, Seattle"},{"name":"Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"17","key":"zoi250868r1","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1002\/cncr.27379","article-title":"Explaining racial differences in prostate cancer mortality.","volume":"118","author":"Taksler","year":"2012","journal-title":"Cancer"},{"key":"zoi250868r2","doi-asserted-by":"publisher","DOI":"10.1097\/01.JU.0001008744.60568.e8.05","article-title":"MP68-05: excess death and potential life years lost among Black prostate cancer patients (1970-2020).","volume":"211","author":"Frimpong","year":"2024","journal-title":"J Urol"},{"issue":"62","key":"zoi250868r5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/jncimonographs\/lgad018","article-title":"Racial disparities in prostate cancer mortality: a model-based decomposition of contributing factors.","volume":"2023","author":"Gulati","year":"2023","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"4","key":"zoi250868r6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.eururo.2022.03.007","article-title":"Deconstructing, addressing, and eliminating racial and ethnic inequities in prostate cancer care.","volume":"82","author":"Nyame","year":"2022","journal-title":"Eur Urol"},{"issue":"5","key":"zoi250868r7","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300289","article-title":"Prostate Cancer Foundation screening guidelines for Black men in the United States.","volume":"3","author":"Garraway","year":"2024","journal-title":"NEJM Evid"},{"issue":"25","key":"zoi250868r8","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1056\/NEJMsb2000250","article-title":"Reconsidering the trade-offs of prostate cancer screening.","volume":"382","author":"Shoag","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi250868r9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.7326\/M16-2586","article-title":"Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO trials.","volume":"167","author":"Tsodikov","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi250868r10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","article-title":"A 16-yr follow-up of the European Randomized Study of Screening for Prostate Cancer.","volume":"76","author":"Hugosson","year":"2019","journal-title":"Eur Urol"},{"issue":"10","key":"zoi250868r11","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/jnci\/djab072","article-title":"The impact of intensifying prostate cancer screening in Black Men: a model-based analysis.","volume":"113","author":"Nyame","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"zoi250868r12","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/1055-9965.EPI-19-1616","article-title":"Diversity of enrollment in prostate cancer clinical trials: current status and future directions.","volume":"29","author":"Rencsok","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"zoi250868r13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/jnci\/djaa171","article-title":"Racial and ethnic variation in PSA testing and prostate cancer incidence following the 2012 USPSTF recommendation.","volume":"113","author":"Kensler","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"zoi250868r15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41239-018-0090-5","article-title":"The contributions of mixed insights to advancing technology-enhanced formative assessments within higher education learning environments: an illustrative example.","volume":"15","author":"Poth","year":"2018","journal-title":"Int J Educ Technol High Educ"},{"issue":"1","key":"zoi250868r16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/CIRCOUTCOMES.112.967885","article-title":"Mixed methods in biomedical and health services research.","volume":"6","author":"Curry","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9","key":"zoi250868r17","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations.","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"issue":"4","key":"zoi250868r19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jama.297.4.407","article-title":"Strategies for academic and clinician engagement in community-participatory partnered research.","volume":"297","author":"Jones","year":"2007","journal-title":"JAMA"},{"key":"zoi250868r20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.691197","article-title":"Attitudes toward and use of prostate-specific antigen testing among urologists and general practitioners in Germany: a survey.","volume":"11","author":"Kappen","year":"2021","journal-title":"Front Oncol"},{"issue":"10","key":"zoi250868r21","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/08870440903194015","article-title":"What is an adequate sample size? operationalising data saturation for theory-based interview studies.","volume":"25","author":"Francis","year":"2010","journal-title":"Psychol Health"},{"key":"zoi250868r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap Consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"zoi250868r25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"3","key":"zoi250868r26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/JU.0000000000002257","article-title":"Representation in online prostate cancer content lacks racial and ethnic diversity: implications for Black and Latinx men.","volume":"207","author":"Loeb","year":"2022","journal-title":"J Urol"},{"issue":"6","key":"zoi250868r27","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/jnci\/djaa172","article-title":"Prostate cancer screening guidelines for Black men: spotlight on an empty stage.","volume":"113","author":"Etzioni","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"zoi250868r28","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement.","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"zoi250868r29","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1001\/jamaoncol.2024.3909","article-title":"How can guidelines give clearer guidance on prostate cancer screening?","volume":"10","author":"Carlsson","year":"2024","journal-title":"JAMA Oncol"},{"issue":"3","key":"zoi250868r30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12160-013-9475-9","article-title":"Effects of patient-provider race concordance and smoking status on lung cancer risk perception accuracy among African-Americans.","volume":"45","author":"Persky","year":"2013","journal-title":"Ann Behav Med"},{"issue":"3","key":"zoi250868r31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s11606-022-07695-y","article-title":"The association of racial and ethnic concordance in primary care with patient satisfaction and experience of care.","volume":"38","author":"Ku","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"12","key":"zoi250868r32","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1158\/1055-9965.EPI-17-0660","article-title":"Impact of patient-provider race, ethnicity, and gender concordance on cancer screening: findings from medical expenditure panel survey.","volume":"26","author":"Malhotra","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"zoi250868r34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.55110","article-title":"Strategies and best practices to improve diversity, equity, and inclusion among US graduate medical education programs.","volume":"6","author":"Boatright","year":"2023","journal-title":"JAMA Netw Open"},{"key":"zoi250868r35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.urology.2021.06.052","article-title":"Formal mentorship as an opportunity to expand the urology pipeline: Under Represented Trainees Entering Residency (UReTER) program evaluation 2020-2021.","volume":"162","author":"Zheng","year":"2022","journal-title":"Urology"},{"key":"zoi250868r36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.urology.2021.08.047","article-title":"The R Frank Jones Urology Interest Group: an intentional and strategic pipeline program to increase diversity in urology.","volume":"162","author":"Wallace","year":"2022","journal-title":"Urology"},{"key":"zoi250868r14","volume-title":"Designing and Conducting Mixed Methods Research","author":"Creswell","year":"2017"},{"key":"zoi250868r22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/B978-0-08-102220-7.00019-4","volume-title":"Research Methods","author":"Williamson","year":"2018","edition":"2nd ed"},{"key":"zoi250868r23","volume-title":"Qualitative Inquiry and Research Design: Choosing Among Five Approaches","author":"Creswell","year":"2013","edition":"3rd ed"},{"key":"zoi250868r3","unstructured":"SEER*Stat Database: incidence - SEER research data, 9 registries, Nov 2019 sub (1975-2017) - linked to county attributes - time dependent (1990-2017) income\/rurality, 1969-2018 counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2020, based on the November 2019 submission. Surveillance, Epidemiology, and End Results Program. Accessed March 19, 2023. https:\/\/www.seer.cancer.gov"},{"key":"zoi250868r4","unstructured":"SEER*Stat Database: incidence - SEER 9 regs research data, Nov 2006 sub (1973-2004) - linked to county attributes - total U.S., 1969-2004 counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2007, based on the November 2006 submission. Surveillance, Epidemiology, and End Results Program. Accessed March 19, 2023. https:\/\/www.seer.cancer.gov"},{"key":"zoi250868r18","unstructured":"Engagement rubric for applicants. Patient-Centered Outcomes Research. Updated June 6, 2016. Accessed July 6, 2021. https:\/\/www.pcori.org\/sites\/default\/files\/Engagement-Rubric.pdf"},{"key":"zoi250868r33","unstructured":"Robeznieks? A. How diversity\u2019s power can help overcome the physician shortage. American Medical Association. May 18, 2022. Accessed March 31, 2025. https:\/\/www.ama-assn.org\/delivering-care\/health-equity\/how-diversity-s-power-can-help-overcome-physician-shortage"},{"key":"zoi250868r37","unstructured":"Prostate cancer facts and statistics. ZERO Prostate Cancer. Accessed June 17, 2025. https:\/\/zerocancer.org\/about-prostate-cancer\/facts-statistics"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2838603\/lee_2025_oi_250868_1756497058.29693.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:00:46Z","timestamp":1757343646000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2838603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.30946","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}